Skip to main content

MILLERKNOLL, INC.

For the period ended Nov 29, 2025. Filed Jan 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Nov 29, 2025 · Filed Jan 5, 2026

MLKN$21.49-2.3%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Item 1. Financial Statements (Unaudited)

Condensed Consolidated Statements of Comprehensive Income (Loss) — Three and Six Months Ended November 29, 2025, and November 30, 20243
Condensed Consolidated Balance Sheets — November 29, 2025, and May 31, 20254
Condensed Consolidated Statements of Cash Flows — Six Months Ended November 29, 2025, and November 30, 20245
Condensed Consolidated Statements of Stockholders' Equity — Six Months Ended November 29, 2025, and November 30, 20246
Notes to Condensed Consolidated Financial Statements
Note 1 - Description of Business and Basis of Presentation8
Note 2 - Recently Issued Accounting Standards9
Note 3 - Revenue from Contracts with Customers9
Note 4 - Inventories11
Note 5 - Goodwill and Indefinite-Lived Intangibles11
Note 6 - Earnings Per Share13
Note 7 - Stock-Based Compensation14
Note 8 - Income Taxes14
Note 9 - Fair Value Measurements15
Note 10 - Commitments and Contingencies19
Note 11 - Short-Term Borrowings and Long-Term Debt20
Note 12 - Accumulated Other Comprehensive Loss22
Note 13 - Operating Segments22
Note 14 - Restructuring and Integration Expense25
Note 15 - Variable Interest Entities28
Item 2 Management's Discussion and Analysis of Financial Condition and Results of Operations29
Item 3 Quantitative and Qualitative Disclosures about Market Risk46
Item 4 Controls and Procedures47
Part II — Other Information
Item 1 Legal Proceedings48
Item 1A Risk Factors48
Item 2 Unregistered Sales of Equity Securities and Use of Proceeds48
Item 5 Other Information48
Item 6 Exhibits48
Signatures50

PART I - FINANCIAL INFORMATION

Condensed Consolidated Statements of Comprehensive Income (Loss)

(Dollars in millions, except share data)Three Months EndedSix Months Ended
(Unaudited)November 29, 2025November 30, 2024November 29, 2025November 30, 2024
Net sales$955.2$970.4$1,910.9$1,831.9
Cost of sales583.0593.41,170.61,118.6
Gross margin372.2377.0740.3713.3
Operating expenses:
Selling, general and administrative298.3289.9592.1588.3
Restructuring expense1.4—1.9—
Design and research24.024.644.347.3
Total operating expenses323.7314.5638.3635.6
Operating earnings48.562.5102.077.7
Interest expense17.920.436.340.3
Interest and other investment income(0.7)(1.5)(1.8)(3.1)
Other (income) expense, net(1.2)(1.3)6.3(2.7)
Earnings before income taxes and equity income32.544.961.243.2
Income tax expense7.39.814.98.7
Equity earnings from nonconsolidated affiliates, net of tax—0.1—0.2
Net earnings25.235.246.334.7
Net earnings attributable to redeemable noncontrolling interests1.01.11.91.8
Net earnings attributable to MillerKnoll, Inc.$24.2$34.1$44.4$32.9
Earnings per share - basic$0.35$0.49$0.65$0.47
Earnings per share - diluted$0.35$0.49$0.64$0.47
Other comprehensive (loss), net of tax
Foreign currency translation adjustments$(9.8)$(36.2)$8.6$(20.8)
Pension and post-retirement liability adjustments0.12.80.22.9
Unrealized (loss) gain on interest rate swap agreement(3.2)3.6(9.0)(17.7)
Other comprehensive (loss), net of tax$(12.9)$(29.8)$(0.2)$(35.6)
Comprehensive income (loss)12.35.446.1(0.9)
Comprehensive income attributable to redeemable noncontrolling interests1.01.11.91.8
Comprehensive income (loss) attributable to MillerKnoll, Inc.$11.3$4.3$44.2$(2.7)

Condensed Consolidated Balance Sheets

(Dollars in millions, except share data)
(Unaudited)November 29, 2025May 31, 2025
ASSETS
Current Assets:
Cash and cash equivalents$180.4$193.7
Accounts receivable, net of allowance of $9.2 and $9.3325.3350.2
Unbilled accounts receivable36.626.9
Inventories477.8447.5
Prepaid expenses82.774.6
Other current assets15.615.8
Total current assets1,118.41,108.7
Property and equipment, at cost1,680.71,638.8
Less — accumulated depreciation(1,179.2)(1,142.7)
Net property and equipment501.5496.1
Right of use assets407.9411.2
Goodwill1,157.41,152.4
Indefinite-lived intangibles434.7432.5
Other amortizable intangibles, net of accumulated amortization of $285.8 and $265.4230.5247.5
Other noncurrent assets96.0101.8
Total Assets$3,946.4$3,950.2
LIABILITIES, REDEEMABLE NONCONTROLLING INTERESTS & STOCKHOLDERS' EQUITY
Current Liabilities:
Accounts payable$257.1$271.3
Short-term borrowings and current portion of long-term debt20.716.0
Accrued compensation and benefits84.092.5
Short-term lease liability77.872.0
Accrued warranty17.016.8
Customer deposits80.2102.5
Other accrued liabilities134.9132.7
Total current liabilities671.7703.8
Long-term debt1,320.91,310.6
Pension and post-retirement benefits7.17.1
Lease liabilities400.7413.4
Other liabilities183.2180.2
Total Liabilities2,583.62,615.1
Redeemable noncontrolling interests63.159.3
Stockholders' Equity:
Preferred stock, no par value (10,000,000 shares authorized, none issued)——
Common stock, $0.20 par value (240,000,000 shares authorized, 68,249,980 and 67,804,913 shares issued and outstanding in fiscal 2026 and 2025, respectively)13.713.6
Additional paid-in capital684.0679.1
Retained earnings684.2665.1
Accumulated other comprehensive loss(82.2)(82.0)
Total Stockholders' Equity1,299.71,275.8
Total Liabilities, Redeemable Noncontrolling Interests, and Stockholders' Equity$3,946.4$3,950.2

Condensed Consolidated Statements of Cash Flows

(Dollars in millions)Six Months Ended
(Unaudited)November 29, 2025November 30, 2024
Cash Flows from Operating Activities:
Net earnings$46.3$34.7
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization72.070.3
Stock-based compensation15.117.9
Amortization of deferred financing costs1.42.3
Loss on extinguishment of debt7.8—
Deferred taxes(0.1)0.9
Restructuring expense2.0—
Increase in current assets(20.7)(75.1)
(Decrease) increase in current liabilities(45.5)18.0
Other, net(4.3)7.4
Net Cash Provided by Operating Activities74.076.4
Cash Flows from Investing Activities:
Advances of notes receivable—(2.3)
Collection of notes receivable1.33.2
Capital expenditures(61.3)(44.9)
Other, net(0.3)(0.8)
Net Cash Used in Investing Activities(60.3)(44.8)
Cash Flows from Financing Activities:
Repayments of long-term debt(605.6)(18.1)
Proceeds from issuance of debt, net of costs544.4—
Payments of deferred financing costs(1.4)—
Proceeds from credit facility659.6486.6
Repayments of credit facility(645.4)(413.5)
Proceeds from securitization facility97.1—
Repayments to securitization facility(42.8)—
Dividends paid(25.6)(26.2)
Common stock issued1.63.4
Common stock repurchases and payments for taxes related to net share settlement of equity awards(12.2)(66.9)
Other, net1.70.8
Net Cash Used in Financing Activities(28.6)(33.9)
Effect of Exchange Rate Changes on Cash and Cash Equivalents1.6(7.0)
Net Decrease in Cash and Cash Equivalents(13.3)(9.3)
Cash and Cash Equivalents, Beginning of Period193.7230.4
Cash and Cash Equivalents, End of Period$180.4$221.1

Condensed Consolidated Statements of Stockholders' Equity

Six Months Ended November 29, 2025
(Dollars in millions, except share data) · Common Stock · Additional Paid-in Capital · Retained Earnings · Accumulated Other Comprehensive Loss · MillerKnoll, Inc. Stockholders' Equity
(Unaudited) · Shares · Amount
May 31, 202567,804,913$13.6$679.1$665.1$(82.0)$1,275.8
Net earnings———20.2—20.2
Other comprehensive loss, net of tax————12.712.7
Stock-based compensation expense——9.3——9.3
Exercise of stock options8,445—0.1——0.1
Restricted and performance stock units released1,030,0340.20.1——0.3
Employee stock purchase plan issuances38,231—0.7——0.7
Repurchase and retirement of common stock and common stock withheld for tax withholdings(377,995)(0.1)(7.1)——(7.2)
Dividends declared ($0.1875 per share)———(13.1)—(13.1)
Other———0.7—0.7
August 30, 202568,503,628$13.7$682.2$672.9$(69.3)$1,299.5
Net earnings———24.2—24.2
Other comprehensive income, net of tax————(12.9)(12.9)
Stock-based compensation expense——5.8——5.8
Exercise of stock options6,500—0.1——0.1
Restricted and performance stock units released14,070—0.3——0.3
Employee stock purchase plan issuances46,301—0.6——0.6
Repurchase and retirement of common stock and common stock withheld for tax withholdings(320,519)—(5.0)——(5.0)
Dividends declared ($0.1875 per share)———(13.1)—(13.1)
Other———0.2—0.2
November 29, 202568,249,980$13.7$684.0$684.2$(82.2)$1,299.7
Six Months Ended November 30, 2024
(Dollars in millions, except share data) · Common Stock · Additional Paid-in Capital · Retained Earnings · Accumulated Other Comprehensive Loss · MillerKnoll, Inc. Stockholders' Equity
(Unaudited) · Shares · Amount
June 1, 202470,377,692$14.1$725.3$738.4$(92.7)$1,385.1
Net (loss)———(1.2)—(1.2)
Other comprehensive income, net of tax————(5.8)(5.8)
Stock-based compensation expense——9.1——9.1
Exercise of stock options71,848—1.5——1.5
Restricted and performance stock units released393,5910.10.1——0.2
Employee stock purchase plan issuances30,002—0.8——0.8
Repurchase and retirement of common stock and common stock withheld for tax withholdings(1,544,733)(0.3)(43.7)——(44.0)
Dividends declared ($0.1875 per share)———(13.2)—(13.2)
August 31, 202469,328,400$13.9$693.1$724.0$(98.5)$1,332.5
Net earnings———34.1—34.1
Other comprehensive income, net of tax————(29.8)(29.8)
Stock-based compensation expense——8.8——8.8
Exercise of stock options21,318—0.4——0.4
Restricted and performance stock units released6,323—0.4——0.4
Employee stock purchase plan issuances32,251—0.7——0.7
Repurchase and retirement of common stock, including excise tax(955,646)(0.2)(23.2)——(23.4)
Directors' fees1,773—0.1——0.1
Dividends declared ($0.1875 per share)———(13.0)—(13.0)
November 30, 202468,434,419$13.7$680.3$745.1$(128.3)$1,310.8

Notes to Condensed Consolidated Financial Statements

(Dollars in millions, except share data)

(unaudited)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.